Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

DHX33 Inhibitors

Chemical inhibitors of DHX33 include a variety of compounds that target different aspects of its enzymatic activity, primarily focusing on the ATPase and RNA helicase functions. Adenosine 5'-triphosphate disodium can directly compete for ATP binding sites on DHX33, which are indispensable for the protein's helicase activity. By occupying these sites, the compound effectively inhibits the ATPase function critical for the unwinding of RNA substrates, a primary role of DHX33. Similarly, Enoxacin and Flavopiridol attack the same ATPase domain, with Enoxacin directly interfering with ATP hydrolysis and Flavopiridol binding to the ATP-binding pocket. Both mechanisms result in the inhibition of DHX33's ability to manipulate RNA structures, which is necessary for its role in RNA metabolism.

Additionally, Aurintricarboxylic acid inhibits DHX33 by a different mechanism, blocking the protein's ability to bind RNA, which is a prerequisite for helicase activity. This binding is also impeded by Myricetin, which intercalates with the RNA substrate, preventing DHX33 from accessing the RNA it needs to unwind. Nucleotide analogs like 5'-Guanylyl imidodiphosphate and Ribavirin interfere with the GTP binding and hydrolysis, with 5'-Guanylyl imidodiphosphate serving as a non-hydrolyzable GTP analog and Ribavirin mimicking guanosine nucleotides, both leading to an inhibition of the GTPase activity essential for DHX33 function. On the other hand, compounds like 2'-Deoxyadenosine 5'-triphosphate and 7-Deazaadenosine compete with ATP, which is indispensable for the catalytic action of DHX33's helicase domain, thereby inhibiting its function. Lastly, general ATPase inhibitors like Suramin and Sodium orthovanadate nonspecifically obstruct the ATP binding required for enzymatic activity, while BX-795, although primarily a kinase inhibitor, blocks the ATP binding site crucial for DHX33's helicase action. Each of these chemicals acts to inhibit the enzymatic activity of DHX33, thereby inhibiting the protein's function in RNA processing and metabolism.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Aurintricarboxylic Acid

4431-00-9sc-3525
sc-3525A
sc-3525B
sc-3525C
100 mg
1 g
5 g
10 g
$20.00
$31.00
$47.00
$92.00
13
(1)

Aurintricarboxylic acid can inhibit DHX33 by preventing the protein from binding to RNA substrates, which is essential for its helicase activity, thereby inhibiting its function in RNA metabolism.

Ribavirin

36791-04-5sc-203238
sc-203238A
sc-203238B
10 mg
100 mg
5 g
$62.00
$108.00
$210.00
1
(1)

Ribavirin can inhibit DHX33 by mimicking the guanosine nucleotide, thereby interfering with the enzymatic processes that require GTP binding and hydrolysis, which are crucial for DHX33's helicase function.

Enoxacin

74011-58-8sc-205670
sc-205670A
500 mg
1 g
$39.00
$48.00
2
(2)

Enoxacin inhibits DHX33 by binding to its ATPase domain and interfering with ATP hydrolysis, which is a critical step in DHX33's RNA helicase activity.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$149.00
$210.00
$714.00
$2550.00
$10750.00
$21410.00
$40290.00
5
(1)

Suramin can inhibit DHX33 by non-specifically binding to the protein's nucleotide-binding domain, which can block ATP binding and hydrolysis, thus inhibiting its helicase function.

BX 795

702675-74-9sc-281689
sc-281689A
sc-281689C
sc-281689B
sc-281689D
sc-281689E
2 mg
5 mg
10 mg
25 mg
50 mg
100 mg
$219.00
$273.00
$331.00
$495.00
$882.00
$1489.00
5
(1)

BX-795 targets the ATP-binding kinase domain, and while it is primarily used for kinase inhibition, it can inhibit DHX33 by blocking its ATP binding site, which is essential for the helicase's ATPase activity.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Flavopiridol inhibits DHX33 by binding to the ATP-binding pocket, which is crucial for the ATPase and helicase activities of DHX33, thus blocking its function in RNA metabolism.

Sodium Orthovanadate

13721-39-6sc-3540
sc-3540B
sc-3540A
5 g
10 g
50 g
$45.00
$56.00
$183.00
142
(4)

Sodium orthovanadate can act as a general ATPase inhibitor and can inhibit DHX33 by competing with ATP, preventing its hydrolysis which is necessary for the helicase activity of DHX33.

Tubercidin

69-33-0sc-258322
sc-258322A
sc-258322B
10 mg
50 mg
250 mg
$184.00
$663.00
$1958.00
(1)

7-Deazaadenosine can inhibit DHX33 by mimicking adenosine and competing with ATP for binding to the ATPase domain, which is essential for the catalytic helicase activity of DHX33.

Myricetin

529-44-2sc-203147
sc-203147A
sc-203147B
sc-203147C
sc-203147D
25 mg
100 mg
1 g
25 g
100 g
$95.00
$184.00
$255.00
$500.00
$1002.00
3
(1)

Myricetin can inhibit DHX33 by intercalating with the RNA substrate, thus preventing the RNA from binding to DHX33 which is necessary for its RNA helicase function.